- Trade rules and agreements can be crucial in determining access to medical technologies. When a trade restriction is not applied correctly or when barriers are put in place which make it difficult for patients to access technologies, this can have an important impact on the sector. MedTech Europe engages in trade negotiations to ensure access to medical technologies around the globe. This includes working on bilateral EU trade agreements as well as engaging with World Trade Organisation activities on technical barriers to trade issues.
- The Transatlantic Trade and Investment Partnership (TTIP), currently under negotiation, could provide a major boost to trade in medical devices and in vitro diagnostics: both industries are specifically mentioned under an initiative to ensure greater transparency in the discussions.
- MedTech Europe is also involved in discussions at the level of the World Customs Organization (WCO) to ensure a clear and consistent application of customs rules to medical technologies. The goal is to facilitate trade, explore questions related to tariffs, and discuss classification of devices under the harmonised system of nomenclature.
Our Priorities International
Trade & Customs
As a global industry, trade negotiations and customs rules play an important role in bringing medical technologies to customers and patients around the world. MedTech Europe is actively engaged in trade and customs issues at European and international level.
International regulator, standards and policy-making bodies play a central role in shaping global healthcare. MedTech Europe engages with stakeholders and decision-makers around the world on issues of common interest.
Medical technology companies operate in diverse global markets. Insights on regulatory, ethical, procurement environment are essential to expanding to new markets.